Atlas Trials

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Clinical trial NCT06989840 · RECRUITING

Trial details

NCT number
NCT06989840
Sponsor
Sagimet Biosciences Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Acne
Start date
2025-06-03
Primary completion
2027-01-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.